On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

InstitutionResearch output, impact & collaborations

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani is a institution indexed in ScholarIQ from OpenAlex.

What is known about Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani?

ScholarIQrecord summary

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani is a research organisation in Rome, IT. OpenAlex records 5,862 works and 778,403 citations for it. 1,293 researchers list it as their most recent affiliation.

How many works does Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani have?

ScholarIQindexed works

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani has 5,862 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani have?

ScholarIQcitation count

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani has 778,403 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani?

ScholarIQresearcher count

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani has 1,293 researchers in the ScholarIQ index.

What is the average h-index at Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani?

ScholarIQavg h-index

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani has an average h-index of 74.5 in OpenAlex.

What is the ROR of Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani?

ScholarIQror

The ROR for Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani is on the source record.

What is the OpenAlex record for Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani?

ScholarIQopenalex

The OpenAlex for Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani is on the source record.

Who are the most-cited researchers behind Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani?

ScholarIQtop researchers by citations
1
Andrea Antinori · HIV/AIDS drug development and treatment
1,086 works37,205 citations
2
Delia Goletti · Tuberculosis Research and Epidemiology
460 works29,259 citations
3
Emanuele Nicastri · COVID-19 Clinical Research Studies
520 works18,974 citations
4
Maria Rosaria Capobianchi · HIV Research and Treatment
653 works17,792 citations

What are the most-cited papers on Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani?

ScholarIQmost cited works
Updated research nosology for HIV-associated neurocognitive disorders
Andrea Antinori, Gabriele Arendt, James T. Becker, Bruce J. Brew, Desiree Byrd, Mariana Cherner, David B. Clifford, Paola Cinque, Leon G. Epstein, Karl Goodkin, Magnus Gisslén, Igor Grant, Robert K. Heaton, Joby Joseph, Karen Marder, Christina M. Marra, Justin C. McArthur, Michael Nunn, Richard W. Price, Lynn Pulliam, K. R. Robertson, Ned Sacktor, Victor Valcour, Valerie Wojna
Neurology. 20072,628 Citations
Towards tuberculosis elimination: an action framework for low-incidence countries
Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D’Ambrosio, Gèrard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovič, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrázola de Oñate, Dráurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela María Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah Monica Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun‐Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O’Donnell, Analita Pace-Asciak, Maria Grazia Pompa, G Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Rühwald, J.P. Sculier, Aleksandar Šimunović, Alison Smith‐Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres‐Duque, Kazunori Umeki, Mukund Uplekar, Catharina Van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin, Mario Raviǵlione
European Respiratory Journal. 2015783 CitationsOPEN ACCESS
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Ivan Solovič, Martina Sester, Juan J. Gómez‐Reino, Hans L. Rieder, Stefan Ehlers, Heather Milburn, Beate Kampmann, Bernhard Hellmich, Richard Groves, Stefan Schreiber, Robert S. Wallis, Giovanni Sotgiu, Elisabeth H. Schölvinck, Delia Goletti, Jean-Pierre Zellweger, Roland Diel, Loreto Carmona, Filippo Bartalesi, Pernille Ravn, Aik Bossink, Raquel Duarte, Connie Erkens, Julia Clark, Giovanni Battista Migliori, Christoph Lange
European Respiratory Journal. 2010525 CitationsOPEN ACCESS
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Andrea Antinori, Roberto Ortiz, Amanda E. Clarke, Chien‐Ching Hung, Jürgen K. Rockstroh, Pierre‐Marie Girard, Jörg Sievers, Choy Man, Alexander Currie, Mark Underwood, Allan R. Tenorio, Keith A. Pappa, Brian Wynne, Anna Fettiplace, Martin Gartland, Michael Aboud, Kimberly Y. Smith, Lidia Isabel Cassetti, Daniel David, Laura Figueras, Marcelo H. Losso, Gustavo Lopardo, Sergio Lupo, Norma Porteiro, Marisa Sánchez, Mark Bloch, D. James Cooper, Robert Finlayson, Anthony D. Kelleher, Kenneth Koh, David Lewis, James McMahon, Richard Moore, Norman Roth, Matt Shields, Stéphane De Wit, Éric Florence, Jean‐Christophe Goffard, Rémy Demeester, Patrick Lacor, Bernard Vandercam, Linos Vandekerckhove, Jonathan B. Angel, Jean‐Guy Baril, Brian Conway, Alexandra de Pokomandy, Jason Szabo, Sharon Walmsley, Olivier Bouchaud, Christian Chidiac, Pierre Delobel, Cécile Goujard, Christine Katlama, Jean‐Michel Molina, Gilles Pialoux, Patrick Philibert, Johannes R. Bogner, Stefan Esser, Ivanka Krznaric, Clara Lehmann, Christoph D. Spinner, Hans‐Jürgen Stellbrink, Christoph Stephan, Albrecht Stoehr, Enrico Barchi, Pietro Caramello, Francesco Castelli, Anna Maria Cattelan, Antonella D'Arminio Monforte, Antonio Di Biagio, Giovanni Di Perri, Andrea Gori, Franco Maggiolo, Barbara Menzaghi, Guglielmo Marco Migliorino, Cristina Mussini, Giovanni Penco, Massimo Puoti, Giuliano Rizzardini, Roberto Gulminetti, Adriano Lazzarin, Tiziano Quirino, Laura Sighinolfi, Pierluigi Viale, Gerardo Amaya Tapia, Jaime Andrade‐Villanueva, Enrique R Granados Reyes, Alma Perez Rios, Mario Santoscoy Gomez, Jan den Hollander, Bart Rijnders, José A. Hidalgo, Luis Hercilla Vásquez, Luis Ricardo Illescas, Anita Olczak, Kamal Mansinho, Patrícia Pacheco
The Lancet. 2018383 CitationsOPEN ACCESS
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
Elisa Benetti, Rossella Tita, Ottavia Spiga, Andrea Ciolfi, Giovanni Birolo, Alessandro Bruselles, Gabriella Doddato, Annarita Giliberti, Caterina Marconi, Francesco Musacchia, Tommaso Pippucci, Annalaura Torella, Alfonso Trezza, Floriana Valentino, Margherita Baldassarri, Alfredo Brusco, Rosanna Asselta, Mirella Bruttini, Simone Furini, Marco Seri, Vincenzo Nigro, Giuseppe Matullo, Marco Tartaglia, Francesca Mari, Elisa Frullanti, Chiara Fallerini, Sergio Daga, Susanna Croci, Sara Amitrano, Francesca Fava, Francesca Montagnani, Laura Di Sarno, Andrea Tommasi, Maria Palmieri, Arianna Emiliozzi, Massimiliano Fabbiani, Barbara Rossetti, Giacomo Zanelli, Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, David Bennet, Federico Anedda, Simona Marcantonio, Sabino Scolletta, Federico Franchi, Maria Antonietta Mazzei, Edoardo Conticini, Luca Cantarini, Bruno Frediani, Danilo Tacconi, Marco Feri, Raffaele Scala, Genni Spargi, Marta Corridi, Cesira Nencioni, Gian Piero Caldarelli, Maurizio Spagnesi, Paolo Piacentini, Maria Bandini, Elena Desanctis, Anna Canaccini, Chiara Spertilli, Alice Donati, Luca Guidelli, Leonardo Croci, Agnese Verzuri, Valentina Anemoli, Agostino Ognibene, Massimo Vaghi, Antonella d’Arminio Monforte, Esther Merlini, Mario U. Mondelli, Stefania Mantovani, Serena Ludovisi, Massimo Girardis, Sophie Venturelli, Marco Sita, Andrea Cossarizza, Andrea Antinori, Alessandra Vergori, Stefano Rusconi, Matteo Siano, Arianna Gabrieli, Agostino Riva, Daniela Francisci, Elisabetta Schiaroli, Pier Giorgio Scotton, Francesca Andretta, Sandro Panese, Renzo Scaggiante, Saverio Giuseppe Parisi, Francesco Castelli, Maria Eugenia Quiros-Roldan, Paola Magro, C Minardi, Deborah Castelli, Itala Polesini, Matteo Della Monica, Carmelo Piscopo
European Journal of Human Genetics. 2020270 CitationsOPEN ACCESS

How much of the research on Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani is open access?

ScholarIQopen access share
92%OPEN ACCESS
Gold
42%
Green
17%
Hybrid
17%
Bronze
17%
Closed
8%

Related on ScholarIQ

470M+ articles · 14-day free trial